| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 141,546 | 136,366 | 132,009 | 154,866 | | Cost of Revenue | 100,517 | 97,196 | 92,828 | 107,058 | | | Gross Profit | 41,029 | 39,170 | 39,181 | 47,808 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 35,995 | 34,321 | 33,973 | 38,435 | | Non Recurring | 334 | 1,552 |
-
| 4,789 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,700 | 3,297 | 5,208 | 4,584 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 97 | 132 | 184 | 298 | | Earnings Before Interest And Taxes | 4,797 | 3,429 | 5,392 | 4,882 | | Interest Expense | 260 | 246 | 191 | 262 | | Income Before Tax | 4,537 | 3,183 | 5,201 | 4,620 | | Income Tax Expense | 23 | 80 | 172 | 328 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,514 | 3,103 | 5,029 | 4,292 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,514 | 3,103 | 5,029 | 4,292 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,514 | $3,103 | $5,029 | $4,292 |
|
0.26% Nasdaq 
Income Statement
